dalteparin has been researched along with Airflow Obstruction, Chronic in 6 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Severe and acute exacerbation of chronic obstructive pulmonary disease (COPD) is associated with a high mortality." | 2.79 | Efficacy of low molecular weight heparin in patients with acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support. ( Qian, Y; Tian, R; Wang, R; Xie, H; Yu, K, 2014) |
| "Venous thromboembolism was previously regarded as a surgical problem, but occurs at least as frequently among medical patients." | 1.32 | Venous thromboembolic risk and prevention in acute medical illness. ( Hampton, KK, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Qian, Y | 1 |
| Xie, H | 1 |
| Tian, R | 1 |
| Yu, K | 1 |
| Wang, R | 1 |
| Modesto-Alapont, M | 1 |
| Nauffal-Manzur, D | 1 |
| Ansótegui-Barrera, E | 1 |
| Menéndez-Villanueva, R | 1 |
| Ballesta, A | 1 |
| Touza, R | 1 |
| Perpiñá-Tordera, M | 1 |
| Kulkarni, SA | 1 |
| Fang, MC | 1 |
| Mattioli, M | 1 |
| Fustini, E | 1 |
| Gennarini, S | 1 |
| Hampton, KK | 1 |
| Brown, RA | 1 |
| Allegra, L | 1 |
| Matera, MG | 1 |
| Page, CP | 1 |
| Cazzola, M | 1 |
3 trials available for dalteparin and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Efficacy of low molecular weight heparin in patients with acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support.
Topics: Acute Disease; Aged; Cohort Studies; Critical Care; Female; Fibrinolytic Agents; Humans; Length of S | 2014 |
[Can home prophylaxis for venous thromboembolism reduce mortality rates in patients with chronic obstructive pulmonary disease?].
Topics: Aged; Female; Heparin, Low-Molecular-Weight; Home Nursing; Humans; Male; Prospective Studies; Pulmon | 2006 |
Additional clinical benefit of enoxaparin in COPD patients receiving salmeterol and fluticasone propionate in combination.
Topics: Aged; Albuterol; Androstadienes; Anticoagulants; Blood Gas Analysis; Bronchodilator Agents; Double-B | 2006 |
3 other studies available for dalteparin and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Bridging Anticoagulation Therapy: A Teachable Moment.
Topics: Accidental Falls; Aged; Anticoagulants; Atrial Fibrillation; Buttocks; Deprescriptions; Embolization | 2020 |
Heart transplant recipient patient with COVID-19 treated with tocilizumab.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Anticoagulants; Cardiomyopathy, Dilated; C | 2020 |
Venous thromboembolic risk and prevention in acute medical illness.
Topics: Acute Disease; Aged; Anticoagulants; Cardiac Output, Low; Enoxaparin; Female; Hospitalization; Human | 2003 |